Loomis, Sayles & Company’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-548	Closed	-$36K	–	747
2024 Q3	$36K	Buy	548 +10	+2%	+$727	﹤0.01%	659
2024 Q2	$50K	Buy	538 +11	+2%	+$974	﹤0.01%	632
2024 Q1	$50K	Sell	527 -6	-1%	-$504	﹤0.01%	618
2023 Q4	$41K	Sell	533 -415	-44%	-$28.9K	﹤0.01%	623
2023 Q3	$66K	Buy	948 +93	+11%	+$7.47K	﹤0.01%	569
2023 Q2	$81K	Buy	855 +408	+91%	+$35.5K	﹤0.01%	552
2023 Q1	$37K	Sell	447 -157	-26%	-$12.3K	﹤0.01%	666
2022 Q4	$45K	Buy	604 +448	+287%	+$34.5K	﹤0.01%	622
2022 Q3	$13K	Sell	156 -879	-85%	-$84.6K	﹤0.01%	650
2022 Q2	$98K	Sell	1,035 -223	-18%	-$23.1K	﹤0.01%	545
2022 Q1	$148K	Buy	1,258 +23	+2%	+$2.58K	﹤0.01%	568
2021 Q4	$160K	Hold	1,235	–	–	﹤0.01%	576
2021 Q3	$140K	Hold	1,235	–	–	﹤0.01%	553
2021 Q2	$128K	Sell	1,235 -16	-1%	-$1.51K	﹤0.01%	554
2021 Q1	$105K	Hold	1,251	–	–	﹤0.01%	554
2020 Q4	$114K	Hold	1,251	–	–	﹤0.01%	526
2020 Q3	$100K	Hold	1,251	–	–	﹤0.01%	537
2020 Q2	$86K	Buy	1,251 +21	+2%	+$1.49K	﹤0.01%	531
2020 Q1	$77K	Hold	1,230	–	–	﹤0.01%	542
2019 Q4	$96K	Buy	+1,230	New	+$96K	﹤0.01%	589